The use of growth factor-based & active ingredients therapy in the immediate post-co2 laser period and following pih: a split-face case report
REPORT summary
Patient
A 48-year-old female underwent fullface fractional CO2 laser resurfacing, evaluated with a split-face design.
Results
This demonstrates that growth factors and ceramides accelerate healing, reduce downtime, and enhance comfort post-laser.
Treatments
Both sides received standard postlaser care, while one additionally received Neauvia Recovery Mask immediately and at 12 h, followed by Neauvia Ceramide Serum at 24 h. The treated side showed faster reduction in erythema, vascularity, thickness, and stiffness, with visibly less redness, lower pain, earlier “white line” recovery, and reduced PIH risk.
PRODUCTS used
discover more
CLINICAL CASES
want to know more about
our treatments?
Neauvia products are for trained experts only. Use must follow approved indications and the Instructions for Use (IFU) in accordance to applicable laws and regulations in each country. Physicians are solely responsible for any treatments outside these conditions. The results shown are specific to an individual treatment plan. Treatment decisions must be adapted to each patient, who may respond differently based on numerous factors. Outcomes are variable and not guaranteed.